PRLD
Prelude Therapeutics Inc
+0.11 (+2.46%)4.58USD270K成交股數365M市值–本益比(近四季)16.3股價營收比–營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 62.5M · 0 |
| 近 180 天 淨額 | 62.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | 04-28 | RA Capital Healthcare Fund LP | TenPercentOwner | J 其他 | 1.4M | – | – | 6.5M | SEC |
| 2026-04-27 | 04-28 | Shah Rajeev M. | TenPercentOwner | J 其他 | 1.4M | – | – | 6.5M | SEC |
| 2026-04-27 | 04-28 | Kolchinsky Peter | TenPercentOwner | J 其他 | 1.4M | – | – | 6.5M | SEC |
| 2026-04-27 | 04-28 | RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | J 其他 | 1.4M | – | – | 6.5M | SEC |
| 2026-04-21 | 04-23 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 1.7M | 4.44 | 7.5M | 11.8M | SEC |
| 2026-04-21 | 04-23 | Bonita David P | Director,TenPercentOwner | P 公開市場買進 | 1.1M | 4.44 | 5.0M | 1.1M | SEC |
| 2026-04-21 | 04-23 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 1.1M | 4.44 | 5.0M | 1.1M | SEC |
| 2026-04-21 | 04-23 | OrbiMed Capital GP VI LLC | Director,TenPercentOwner | P 公開市場買進 | 1.1M | 4.44 | 5.0M | 1.1M | SEC |
| 2026-04-21 | 04-23 | ORBIMED CAPITAL LLC | Director,TenPercentOwner | P 公開市場買進 | 1.1M | 4.44 | 5.0M | 1.1M | SEC |
| 2026-04-21 | 04-23 | OrbiMed Genesis GP LLC | Director,TenPercentOwner | P 公開市場買進 | 1.7M | 4.44 | 7.5M | 11.8M | SEC |
| 2026-04-21 | 04-23 | OrbiMed Capital GP VI LLC | Director,TenPercentOwner | P 公開市場買進 | 1.7M | 4.44 | 7.5M | 11.8M | SEC |
| 2026-04-21 | 04-23 | Bonita David P | Director,TenPercentOwner | P 公開市場買進 | 1.7M | 4.44 | 7.5M | 11.8M | SEC |
| 2026-04-21 | 04-23 | ORBIMED CAPITAL LLC | Director,TenPercentOwner | P 公開市場買進 | 1.7M | 4.44 | 7.5M | 11.8M | SEC |
| 2026-04-21 | 04-23 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 1.1M | 4.44 | 5.0M | 1.1M | SEC |
| 2025-10-04 | 10-07 | Huang Jane | President, CMO | F 繳稅扣股 | 3.4K | 1.47 | 5K | 86.9K | SEC |
| 2025-10-04 | 10-07 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 90.3K | SEC |
| 2025-07-04 | 07-08 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 84.3K | SEC |
| 2025-07-04 | 07-08 | Huang Jane | President, CMO | F 繳稅扣股 | 3.4K | 0.79 | 3K | 80.9K | SEC |
| 2025-04-04 | 04-07 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 78.2K | SEC |
| 2025-04-04 | 04-07 | Huang Jane | President, CMO | F 繳稅扣股 | 3.4K | 0.68 | 2K | 74.9K | SEC |
| 2025-03-25 | 03-27 | Combs Andrew | Chief Chemistry Officer | P 公開市場買進 | 100K | 0.69 | 69K | 480K | SEC |
| 2025-03-25 | 03-27 | Vaddi Krishna | CEO | P 公開市場買進 | 675K | 0.69 | 466K | 2.0M | SEC |
| 2025-03-21 | 03-24 | Vaddi Krishna | CEO | P 公開市場買進 | 15.0K | 0.73 | 11K | 1.3M | SEC |
| 2025-03-20 | 03-24 | Vaddi Krishna | CEO | P 公開市場買進 | 5.4K | 0.73 | 4K | 1.3M | SEC |
| 2025-03-17 | 03-18 | Vaddi Krishna | CEO | P 公開市場買進 | 9.1K | 0.75 | 7K | 1.3M | SEC |
| 2025-03-14 | 03-18 | Vaddi Krishna | CEO | P 公開市場買進 | 30.0K | 0.75 | 22K | 1.3M | SEC |
| 2025-03-13 | 03-14 | Vaddi Krishna | CEO | P 公開市場買進 | 50.0K | 0.72 | 36K | 1.3M | SEC |
| 2025-03-12 | 03-14 | Vaddi Krishna | CEO | P 公開市場買進 | 47.5K | 0.71 | 34K | 1.2M | SEC |
| 2025-01-04 | 01-07 | Huang Jane | President, CMO | F 繳稅扣股 | 3.9K | 1.39 | 5K | 68.9K | SEC |
| 2025-01-04 | 01-07 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 72.7K | SEC |
| 2024-12-31 | 01-03 | Vaddi Krishna | CEO | P 公開市場買進 | 5.0K | 1.21 | 6K | 143K | SEC |
| 2024-12-30 | 01-02 | Vaddi Krishna | CEO | P 公開市場買進 | 10.0K | 1.20 | 12K | 138K | SEC |
| 2024-12-23 | 12-26 | Combs Andrew | Chief Chemistry Officer | P 公開市場買進 | 60.0K | 1.37 | 82K | 378K | SEC |
| 2024-12-20 | 12-26 | Combs Andrew | Chief Chemistry Officer | P 公開市場買進 | 3.1K | 1.15 | 4K | 318K | SEC |
| 2024-12-19 | 12-20 | Lim Bryant David | CLO, Interim CFO, Corp Sec. | P 公開市場買進 | 25.0K | 0.91 | 23K | 27.4K | SEC |
| 2024-12-19 | 12-20 | Vaddi Krishna | CEO | P 公開市場買進 | 6.9K | 0.89 | 6K | 128K | SEC |
| 2024-12-18 | 12-20 | Vaddi Krishna | CEO | P 公開市場買進 | 100K | 0.93 | 93K | 1.2M | SEC |
| 2024-10-04 | 10-07 | Huang Jane | President, CMO | F 繳稅扣股 | 3.3K | 2.00 | 7K | 63.3K | SEC |
| 2024-10-04 | 10-07 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 66.7K | SEC |
| 2024-07-04 | 07-08 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 60.7K | SEC |
| 2024-07-04 | 07-08 | Huang Jane | President, CMO | F 繳稅扣股 | 3.3K | 3.60 | 12K | 57.3K | SEC |
| 2024-04-04 | 04-08 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 54.6K | SEC |
| 2024-04-04 | 04-08 | Huang Jane | President, CMO | F 繳稅扣股 | 3.3K | 4.74 | 16K | 51.3K | SEC |
| 2024-01-04 | 01-08 | Huang Jane | President, CMO | F 繳稅扣股 | 3.8K | 3.77 | 14K | 45.3K | SEC |
| 2024-01-04 | 01-08 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 49.1K | SEC |
| 2023-10-04 | 10-06 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 39.7K | SEC |
| 2023-07-04 | 07-06 | Huang Jane | President, CMO | F 繳稅扣股 | 3.2K | 4.65 | 15K | 30.4K | SEC |
| 2023-07-04 | 07-06 | Huang Jane | President, CMO | M 選擇權執行 | 9.4K | – | – | 33.6K | SEC |
| 2023-05-25 | 05-26 | Vaddi Krishna | CEO | P 公開市場買進 | 900 | 5.31 | 5K | 1.1M | SEC |
| 2023-05-24 | 05-26 | Vaddi Krishna | CEO | P 公開市場買進 | 1.0K | 5.01 | 5K | 1.1M | SEC |
| 2023-05-24 | 05-25 | Lim Bryant David | Chief Legal Officer, Corp Sec. | P 公開市場買進 | 2.4K | 5.39 | 13K | 2.4K | SEC |
| 2023-05-23 | 05-25 | Chardonnet Laurent | Chief Financial Officer | P 公開市場買進 | 5.0K | 5.50 | 28K | 42.2K | SEC |
| 2023-05-23 | 05-25 | Vaddi Krishna | CEO | P 公開市場買進 | 11.9K | 5.63 | 67K | 1.1M | SEC |
| 2023-05-22 | 05-24 | Bonita David P | Director,TenPercentOwner | P 公開市場買進 | 870K | 5.75 | 5.0M | 10.1M | SEC |
| 2023-05-22 | 05-24 | OrbiMed Capital GP VI LLC | Director,TenPercentOwner | P 公開市場買進 | 870K | 5.75 | 5.0M | 10.1M | SEC |
| 2023-05-22 | 05-24 | ORBIMED CAPITAL LLC | Director,TenPercentOwner | P 公開市場買進 | 870K | 5.75 | 5.0M | 10.1M | SEC |
| 2023-05-22 | 05-24 | ORBIMED ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 870K | 5.75 | 5.0M | 10.1M | SEC |
| 2023-04-06 | 04-06 | Huang Jane | President, CMO | S 公開市場賣出 | 13.3K | 6.12 | 81K | 24.2K | SEC |
| 2023-04-04 | 04-06 | Huang Jane | President, CMO | M 選擇權執行 | 37.5K | – | – | 37.5K | SEC |
| 2022-12-20 | 12-21 | Vaddi Krishna | CEO | P 公開市場買進 | 19.2K | 5.13 | 98K | 121K | SEC |
| 2022-12-08 | 12-12 | Chardonnet Laurent | Chief Financial Officer | P 公開市場買進 | 10.0K | 4.76 | 48K | 35.9K | SEC |
| 2022-06-01 | 06-01 | Chardonnet Laurent | Chief Financial Officer | P 公開市場買進 | 10.0K | 4.23 | 42K | 24.5K | SEC |
| 2022-03-31 | 04-04 | Combs Andrew | EVP, Head of Chemistry | M 選擇權執行 | 36.1K | 1.89 | 68K | 304K | SEC |
| 2022-03-21 | 03-22 | Chardonnet Laurent | Chief Financial Officer | A 獲配股票 | 6.5K | 7.51 | 49K | 14.5K | SEC |
| 2021-12-15 | 12-17 | Morosini Deborah | EVP, Chief of Clinical Affairs | M 選擇權執行 | 25.7K | 12.85 | 331K | 29.2K | SEC |
| 2021-12-15 | 12-17 | Morosini Deborah | EVP, Chief of Clinical Affairs | M 選擇權執行 | 3.0K | 1.89 | 6K | 3.5K | SEC |
| 2021-12-15 | 12-17 | Morosini Deborah | EVP, Chief of Clinical Affairs | S 公開市場賣出 | 28.8K | 13.00 | 374K | 444 | SEC |
| 2021-12-14 | 12-15 | Combs Andrew | EVP, Head of Chemistry | P 公開市場買進 | 4.0K | 11.60 | 46K | 268K | SEC |
| 2021-12-13 | 12-15 | Combs Andrew | EVP, Head of Chemistry | P 公開市場買進 | 4.0K | 12.12 | 48K | 264K | SEC |
| 2021-12-13 | 12-14 | Chardonnet Laurent | Chief Financial Officer | A 獲配股票 | 5.0K | 12.28 | 61K | 8.0K | SEC |
| 2021-12-13 | 12-14 | Vaddi Krishna | President, CEO | A 獲配股票 | 8.0K | 12.13 | 97K | 1.1M | SEC |
| 2021-11-16 | 11-18 | Morosini Deborah | EVP, Chief of Clinical Affairs | M 選擇權執行 | 28.8K | 12.85 | 369K | 29.2K | SEC |
| 2021-11-16 | 11-18 | Morosini Deborah | EVP, Chief of Clinical Affairs | S 公開市場賣出 | 400 | 16.43 | 7K | 444 | SEC |
| 2021-11-16 | 11-18 | Morosini Deborah | EVP, Chief of Clinical Affairs | S 公開市場賣出 | 28.4K | 15.87 | 450K | 844 | SEC |
| 2021-10-05 | 10-06 | Mauro David J | Chief Medical Officer | M 選擇權執行 | 15.0K | 1.89 | 28K | 15.0K | SEC |
| 2021-10-05 | 10-06 | Mauro David J | Chief Medical Officer | S 公開市場賣出 | 1.3K | 32.06 | 41K | 0 | SEC |
| 2021-10-05 | 10-06 | Mauro David J | Chief Medical Officer | S 公開市場賣出 | 7.8K | 31.30 | 244K | 1.3K | SEC |
| 2021-10-05 | 10-06 | Mauro David J | Chief Medical Officer | S 公開市場賣出 | 5.9K | 30.26 | 179K | 9.1K | SEC |
| 2021-09-07 | 09-09 | Mauro David J | Chief Medical Officer | S 公開市場賣出 | 7.5K | 35.91 | 269K | 7.5K | SEC |
| 2021-09-07 | 09-09 | Mauro David J | Chief Medical Officer | M 選擇權執行 | 15.0K | 1.89 | 28K | 15.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13.7M | 73.2M | +2.8M (+26%) | 加碼 |
| BAKER BROS. ADVISORS LP | 10.1M | 54.0M | 不變 | 持平 |
| RA CAPITAL MANAGEMENT, L.P. | 6.5M | 34.5M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 3.4M | 18.0M | 新進 | 新進 |
| Kynam Capital Management, LP | 2.4M | 12.9M | +823K (+52%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 10.7M | +779K (+63%) | 加碼 |
| BlackRock, Inc. | 1.8M | 9.6M | +1.5M (+458%) | 加碼 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.0M | 5.4M | +461K (+83%) | 加碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 993K | 5.3M | +69.7K (+8%) | 加碼 |
| ADAR1 Capital Management, LLC | 901K | 4.8M | +748K (+489%) | 加碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 845K | 4.5M | +462K (+121%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 842K | 4.5M | +539K (+178%) | 加碼 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 766K | 4.1M | 新進 | 新進 |
| MORGAN STANLEY | 504K | 2.7M | +182K (+56%) | 加碼 |
| STATE STREET CORP | 429K | 2.3M | +291K (+210%) | 加碼 |
| UBS Group AG | 319K | 1.7M | +254K (+394%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 285K | 1.5M | +128K (+81%) | 加碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 281K | 1.5M | +6.0K (+2%) | 加碼 |
| NORTHERN TRUST CORP | 241K | 1.3M | +190K (+380%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 194K | 1.0M | 新進 | 新進 |
| MARSHALL WACE, LLP | 191K | 1.0M | −168K (-47%) | 減碼 |
| Connor, Clark & Lunn Investment Management Ltd. | 126K | 669K | +16.5K (+15%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 121K | 644K | −116K (-49%) | 減碼 |
| Hillsdale Investment Management Inc. | 81.4K | 434K | 新進 | 新進 |
| Bank of New York Mellon Corp | 68.2K | 363K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 75 +20 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 34 / 14 / 25 / 8 |
| 機構合計持股 · 佔流通股 | 49.6M · 62.2% |
| 合計季末市值 | 261M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.6M |
|---|---|
| 與上期比 | -5.8% |
| 佔流通股數 | 4.50% |
| 日均成交量 | 643K |
| 回補天數 | 5.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.6M | -5.8% | 4.50% | 643K | 5.6 |
| 2026-08-14 | 3.8M | +4.0% | 4.78% | 391K | 9.8 |
| 2026-07-31 | 3.7M | +11.7% | 4.60% | 394K | 9.3 |
| 2026-07-15 | 3.3M | +16.4% | 4.12% | 345K | 9.5 |
| 2026-06-30 | 2.8M | +57.4% | 3.54% | 812K | 3.5 |
| 2026-06-15 | 1.8M | +5.8% | 2.25% | 286K | 6.3 |
| 2026-05-29 | 1.7M | -8.5% | 2.12% | 315K | 5.4 |
| 2026-05-15 | 1.9M | +19.1% | 2.32% | 523K | 3.5 |
| 2026-04-30 | 1.6M | -14.0% | 1.95% | 580K | 2.7 |
| 2026-04-15 | 1.8M | -22.1% | 2.27% | 348K | 5.2 |
| 2026-03-31 | 2.3M | +1.9% | 2.91% | 169K | 13.8 |
| 2026-03-13 | 2.3M | +0.1% | 2.85% | 281K | 8.1 |
| 2026-02-27 | 2.3M | -4.5% | 2.85% | 365K | 6.2 |
| 2026-02-13 | 2.4M | +14.7% | 2.98% | 267K | 8.9 |
| 2026-01-30 | 2.1M | +23.7% | 2.60% | 434K | 4.8 |
| 2026-01-15 | 1.7M | +13.9% | 2.10% | 539K | 3.1 |
| 2025-12-31 | 1.5M | +15.1% | 1.85% | 562K | 2.6 |
| 2025-12-15 | 1.3M | +28.5% | 1.60% | 385K | 3.3 |
| 2025-11-28 | 996K | -22.1% | 1.25% | 486K | 2.1 |
| 2025-11-14 | 1.3M | +125.3% | 1.60% | 6.9M | 1.0 |
| 2025-10-31 | 567K | +10.1% | 0.71% | 268K | 2.1 |
| 2025-10-15 | 515K | -14.3% | 0.65% | 216K | 2.4 |
| 2025-09-30 | 601K | +11.7% | 0.75% | 370K | 1.6 |
| 2025-09-15 | 538K | +1.4% | 0.67% | 133K | 4.1 |
| 2025-08-29 | 531K | +4.1% | 0.67% | 304K | 1.8 |
| 2025-08-15 | 510K | -14.2% | 0.64% | 113K | 4.5 |